Sarepta Therapeutics | SRPT - 流動負債





流動負債 変化する 日付
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Agios Pharmaceuticals USD 70.22M 11.37M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amgen USD 24.96B 534M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Biogen USD 3.92B 918.2M 2026-06
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Capricor Therapeutics USD 33.64M 2.2M 2026-03
Daiichi Sankyo JPY 765.7B 119.32B 2026-06
Eli Lilly USD 36.63B 1.41B 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Incyte USD 1.31B 177.55M 2026-06
Insmed USD 361.01M 107.87M 2026-03
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
Moderna USD 2.53B 139M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Novavax USD 342.46M 117.49M 2026-03
Pfizer USD 32.65B 1.7B 2026-06
PTC Therapeutics USD 771.07M 152.54M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 31.93B 1.92B 2026-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06